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Abstract
Background: After ovulation in the cow, the corpus luteum (CL) rapidly develops within a few days with
angiogenesis and progesterone production. CL formation resembles an inflammatory response due to the influx of
immune cells. Neutrophils play a role in host defense and inflammation, and secrete chemoattractants to stimulate
angiogenesis. We therefore hypothesized that neutrophils infiltrate in the developing CL from just after ovulation
and may play a role in angiogenesis of the CL.
Methods and Results: Polymorphonuclear neutrophils (PMN) were detected in CL tissue by Pas-staining, and
interleukin-8 (IL-8, a neutrophil-specific chemoattractant) was measured in supernatant of the CL tissue culture:
considerable amounts of PMNs and the high level of IL-8 were observed during the early luteal phase (days 1-4 of
the estrous cycle). PMNs and IL-8 were low levels in the mid and late luteal phases, but IL-8 was increased during
luteal regression. The PMN migration in vitro was stimulated by the supernatant from the early CL but not from
the mid CL, and this activity was inhibited by neutralizing with an anti-IL-8 antibody, indicating the major role of
IL-8 in inducing active PMN migration in the early CL. Moreover, IL-8 stimulated proliferation of CL-derived
endothelial cells (LECs), and both the supernatant of activated PMNs and IL-8 stimulated formation of capillary-like
structures of LECs.
Conclusion: PMNs migrate into the early CL partially due to its major chemoattractant IL-8 produced at high levels
in the CL, and PMNs is a potential regulator of angiogenesis together with IL-8 in developing CL in the cow.
Background
T h ec o r p u sl u t e u m( C L )i sau n i q u ee n d o c r i n eo r g a n
that develops from the ovulated follicle during the sex-
ual cycle. The main function of the CL is to secrete a
large amount of progesterone (P), which is essential for
establishment and maintenance of pregnancy. After ovu-
lation, inadequate function of the CL is one of major
causes of infertility in cows [1]. Angiogenesis is funda-
mental to the normal development of the CL in many
species. One of the major angiogenic factors, basic fibro-
blast growth factor (FGF2), is generally involved in cell
growth, differentiation, transformation and angiogenesis.
Gospodarowizc et al. [2] have been shown that FGF2 is
produced in the bovine CL and stimulates neovasculari-
zation and proliferation of a wide variety of cells, such
as vascular smooth muscle cells, granulosa cells and
endothelial cells. Additionally, vascular endothelial
growth factor A (VEGFA, mainly localized in the cyto-
plasm of luteal cells) also is major player for angiogen-
esis and plays a fundamental role in maintenance of the
vasculature in the CL when it is no longer undergoing
active angiogenesis [3].
Cytokines and chemokines, such as prostaglandins
(PGs) [4], tumor necrosis factor a (TNFa) [5], interleu-
kin (IL)-1 [6] and IL-8 [7,8] are found in high concen-
trations in the follicular fluid in the pre-ovulatory phase.
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phages infiltrate in the pre-ovulatory follicle at the time
of ovulation [9]. Indeed, neutrophil depletion by admin-
istration of a monoclonal antibody against neutrophils
reduced the ovulation rate in rats, indicating a critical
role for neutrophils in ovulation [10]. After ovulation, a
multitude of leukocytes, such as macrophages and eosi-
nophils are located in the luteinizing theca area in the
developing CL [11-13]. This series of phenomena from
ovulation to luteal development involves bleeding,
immune cell infiltration, tissue remodeling and angio-
genesis, implying that the development of the CL fol-
lowing ovulation is a kind of physiological injury with
an inflammatory response. In general, polymorphonuc-
lear neutrophils (PMN) are the first cells recruited to
inflammatory sites, providing cytokines and proteolytic
enzymes. Moreover, PMNs secrete VEGFA [14] and
induce the sprouting of capillary-like structures of
endothelial cells in vitro [15], suggesting that PMNs
have a potential role, not only in phagocytosis, but also
in the regulation of angiogenesis.
IL-8 is a small protein (8.4 kDa) and produced by
macrophages, endothelial cells and neutrophils [15,16].
IL-8 has been shown to be a neutrophil-specific che-
moattractant [16], and IL-8 is involved in angiogenesis,
cell proliferation, and apoptosis [16,17]. In the ovary, IL-
8 is detected in theca, granulosa, granulosa-lutein, and
vascular endothelial cells in humans [18,19] and rabbits
[20]. Goto et al,[ 2 1 ]o b s e r v e dt h a tI L - 8i n j e c t i o n
increased follicular growth and capillary vessel densities
around the follicles in rats. Furthermore, treatment of
anti-IL-8 antibody inhibited the hCG-induced ovulation
rate [22], suggesting that IL-8 participates in the regula-
tion of ovarian function to induce ovulation. However,
no evidence has been shown regarding the role of neu-
trophils and IL-8 in the life span of the bovine CL.
We hypothesized that PMNs infiltrate in the develop-
i n gC Lf r o mj u s ta f t e ro v u l a t i o na n dm a yp l a yar o l ei n
angiogenesis of the CL. Therefore, in the present study,
we investigated the localization of PMNs and their che-
moattractant, IL-8, in the bovine CL during the estrous
cycle and effects of PMNs and IL-8 on the function of
luteal endothelial cells in vitro.
Methods
Experiment 1: the estrous cycle
Ovaries were collected from a local slaughterhouse and
CLs were classified according to stage of the estrous
cycle by macroscopic observation (color and size of the
CL) and weigh of the CL as described previously [23].
The stages of the estrous cycle were estimated as fol-
lows: early, (i) days 1-2, (ii) days 3-4, (iii) days 5-7; mid,
days 8-12; late, days 13-16; and luteal regression, days
18 or greater of the estrous cycle (n = 4-5 in each
stage). To use immunohistochemical analysis, CL sam-
ples were fixed with 10% formaldehyde for 24 h, and
embedded in paraffin wax according to the standard of
histological technique. In addition, CL was minced and
approximately 0.1 g of luteal tissues was placed into a
1.5-ml microcentrifuge tube with 400 μlo fT R I z o l
reagent (Gibco BRL, Gaithersburg, MD) and stored at
-80°C for further analyzed. Also, to detect IL-8 concen-
tration from the CL, the early- (days 3-4), mid-, late and
regressing phase of CLs were cut into cubes (length, 4
mm; side, 2 mm; thickness, 2 mm; n = 4-5 in each
stage). The CL tissues were washed in DMEM/F-12
(Invitrogen Corporation, Tokyo, Japan) with 0.1% fetal
bovine serum (FBS; Invitrogen Corporation) for 15 min.
Subsequently, the CL tissues were rinsed with phosphate
buffered saline (PBS) to eliminate the effect of the FBS
and transferred to serum-free DMEM/F-12 medium
medium containing 0.1% BSA, 0.1% gentamicin solution
( 5 0m g / L ,S I G M A ,S t .L o u i s ,M O ,U S A ) ,a n d1 %
amphotericin B solution (2.5 mg/L, SIGMA). CL tissue
was set in a 48-well plate (1 tissue/well). Incubation was
carried out for 8 h at 37°C. Then, supernatant of the CL
tissue was harvested, and IL-8 within the supernatant
was measured using an ELISA kit for bovine IL-8
(USCN Life Science Inc., Wuhan, China). The standard
curve for IL-8 ranged from 15.6 to 1000 pg/ml.
Luteal cells (LCs) and luteal endothelial cells (LECs) culture
The CLs of the mid luteal phase were collected at local
slaughterhouse, and dispersed using collagenase IV
(SIGMA). The luteal stages were classified as mid (days
8-12 of the estrous cycle) by macroscopic observation of
the ovary as described previously [24]. LCs was isolated
from the bovine mid CL (Days 8-12 of the estrous
cycle) using magnetic tosylactivated beads coating with
BS-1 lectin (binds glycoproteins on the bovine endothe-
lial cells), BS-1 negative cells were assessed as enriched
LCs (including smooth muscle cells and pericytes) as
described previously [25]. Before experiment, we con-
firmed the mRNA expression of steroidogenic acute reg-
ulatory protein and endothelial nitric oxide synthase as a
maker of LCs in BS-1 negative cells and a maker of
LECs in BS-1 positive cells, respectively (data not
shown). LCs were cultured in DMEM/F-12 medium
containing 5% FBS, 2.2% NaHCO3, gentamicin solution,
and amphotericin B solution. Cytokeratin- negative
LECs isolated from the CLs of the cows during the mid-
luteal phase were used as described previously [26].
LECs were grown on plates pre-coated with 1% Vitrogen
in DMEM/F-12 medium containing 5% FBS, 2.2%
NaHCO3, gentamicin, and amphotericin B solution. All
experiments in the present study were carried out on
LECs from passages 5 to 8. For analysis of mRNA
expression, LCs and LECs were cultured for 24 h at 37°
C, then placed into a 1.5-mL microcentrifuge tube with
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analysis.
Experiment 2: PMN migration capacity of early- and mid-
phase luteal tissue
PMN isolation
Whole blood (20 ml) was mixed with an equal volume of
PBS. The suspension was layered onto Ficoll-Paque solu-
tion (Lymphoprep, AXIS-SHIELD, Norway) and then
centrifuged at 1000 × g at 10°C for 30 min as described
previous study [27,28]. The plasma and buffy coat (popu-
lation of mononuclear cells) were discarded. Contaminat-
ing red blood cells were washed in hypotonic distilled
water for approximately 10 sec. Isotonicity was restored
by the addition of twice concentrated-PBS. PMNs were
c e n t r i f u g e da t5 0 0×g at 10°C for 10 min and then the
cell pellet was washed twice with PBS. Isolated PMNs
were resuspended at a concentration of 2 × 10
6 cells/ml
in RPMI 1640 (Invitrogen) with 0.1% FBS. PMNs viability
was 99% as assessed by the Trypan blue staining. To
check the purity of PMNs before using for the experi-
ment, the purity of PMNs was > 95% and these cells
resulted in nearly pure granulocyte populations as deter-
mined by flow cytometric evaluation (Beckman Coulter,
Inc., CA, UAS) [27,28]. Additionally, we observed
giemsa-stained PMNs by microscope, these cells were
clear granule and segmented nuclear. Although periph-
eral granulocytes include neutrophils, eosinophils and
basophils in generally, the purity of neutrophils (2-5
lobes of nuclear and finely-granular) was > 95% in these
PMNs by microscope observation in the present study
since character was different between neutrophils and
eosinophils (double nuclear and coarsely-granular).
Migration assay by culture medium and detection of IL-8
Supernatants of the early- (days 3-4) and mid- (days 8-
12) phase CLs were used (n = 4 in each stage) as
described above. PMN chemotaxis was evaluated using a
10-well microchemotaxis chamber (Neuro Probe, Inc.,
Gaithersburg, MD, USA). Test solutions in the bottom
chamber were separated from leukocytes in the upper
chamber by an 8- μm pore-sized filter (Neuro Probe,
Inc.). The following solutions (300 μL) were pipetted
into the bottom chamber: (i) medium alone, (ii) super-
natant derived from the early- or mid-phase CL tissue
culture, and (iii) recombinant bovine IL-8 (50 ng/ml) as
a positive control. After instrument assembly, PMNs
were added to the upper chamber (250 μl/well; 2 × 10
6
cells/ml). After a 3 h incubation at 37°C in 5% CO2,
migrated cells in the bottom chamber were counted
using a light microscope.
Inhibition of IL-8 function in PMN migration in early-phase
CL supernatan
To investigate the possible role of IL-8 as a neutrophil-
specific chemoattractant in early-phase CL tissue culture
supernatant, we inhibited IL-8 function using anti-IL-8
monoclonal antibody reacted with bovine IL-8 (Ab;
MAB1044, Millipore Corporation, Australia) and then
performed a transmigration assay. The supernatant of
each CL was incubated with anti-IL-8 Ab (30 μg/ml) or
same dose of normal IgG as control at 37°C for 1 h in
duplicates (n = 4 in each group). Following incubation,
media were analyzed for PMN migration as described
above. The following solutions (300 μl) were pipetted to
the bottom chamber: (i) medium alone, (ii) supernatant
derived from the early CL culture with or without IL-8
Ab pre-treatment, and (iii) recombinant IL-8 (50 ng/ml)
as a positive control. After instrument assembly, PMNs
were added to the upper chamber (250 μl/well; 2 × 10
6
cells/ml). After incubation at 37°C in 5% CO2 for 3 h,
migrated cells in the bottom chamber were counted
using a light microscope.
Experiment 3: effect of PMNs and IL-8 on live cell number
of luteal endothelial cells and capillary tube formation
Live cell number of luteal endothelial cells
LECs as described above was used in the experiment.
These cells were grown in DMEM/F-12 containing 5%
FBS (1 × 10
5 cells/well in 24-well plates) for 24 h at 37°
C. Then, LECs were rinsed with PBS twice, and fresh
medium was replaced with medium containing IL-8 (1,
10 and 100 ng/ml) for 48 h in DMEM/F-12 medium
containing 0.1% FBS. Then, cells were trypsinization and
the number of LECs was counted by light microscope as
live cell number of LEC without dead cells staining with
Trypan blue.
Capillary tube formation on matrigel of luteal endothelial
cells
Capillary-like tube formation of LECs was evaluated as
previously described [29]. Briefly, 48-well plate was
coated with 200 μl/well of BD matrigelTM basement
membrane (BD biosciences, Bedford, MA, USA) at 4°C,
which was then allowed to polymerize at 37°C for at
least 1 h. LECs (2 × 10
4 cells/well) were cultured in a
final volume of 0.5 ml in LEC culture medium contain-
ing IL-8 (1, 10 and 100 ng/ml) or the supernatants from
PMNs (n = 4 in each group). To obtain the supernatant
from PMNs, PMNs from the early luteal phase were cul-
tured in 48-well plates (1 × 10
6 cells/well) in the pre-
sence of N-formyl-methionyl-leucyl-phenylalanine
(fMLP, 10 and 100 nM) or without fMLP as control for
1 h at 37°C as previously described [15]. After stimula-
tion of PMNs with fMLP, supernatant of activated
PMNs were harvested and used for the assessment of
capillary tube formation (n = 4 in each group). After 8 h
incubation, tube formation was examined visually in
three random images imported at a magnification of
100× by inverted microscope, and the length and the
area of tubular structure in each image (1 × 1 mm)
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Data are shown as mean ± SEM.
Histology and PMNs counting In experiment 1, PMNs
were detected using paraffin sections stained with peri-
odic acid - Schiff’s (PAS) reagent for 10 min, and then
counterstained with hematoxylin (Certistain, Merck,
Germany) [30]. This PAS stain was used on each tissue
block, and 5 fields per section were examined at × 400
magnification. Although red blood cells and other
immune cells, such as macrophages are stained in the
CL tissue, therefore in addition to positive cells by PAS
staining, we checked the shape of nuclear of cells and
assessed segmented granulocytes as PMNs. Thus, we
could distinguish PMNs especially neutrophils from
other PAS stained positive cells, such as red blood cells
and macrophages. Quantification of the number of
PMNs was performed independently by 3 observers.
The numbers of PMNs/0.04 mm
2 (200 × 200 μm) were
independently counted under a light microscope. Intra-
and inter-observer differences were < 10%. Data are
shown as mean ± SEM.
RNA isolation and real-time PCR
Total RNA was extracted following the protocol of
Chomczynski and Sacchi using TRIzol reagent [31] as in
our previous study [32]. The extracted total RNA was
stored in RNA storage solution (Ambion, Texas, USA)
at -80°C until use for cDNA production. RNA samples
were treated with DNase using the RQ1 RNase-Free
DNase kit (Promega. Co., Madison, WI, USA) as in our
previous study [32]. The synthesized cDNA was stored
at -30°C.
PCRs were quantified using a LightCycler (Roche
Diagnostics, Indianapolis, IN, USA) and a commercial
kit (LightCycler FastStart DNA Master SYBR Green I,
Roche Diagnostics) as describe previously [32]. The
quantification of mRNA expression was performed
using Light Cycler Software (Version 3.5; Roche
Diagnostics). The primers used for real-time PCR were
as follows: IL-8 (NM_173925, 170 bp), forward, 5-
CCTCTTGTTCAATATGACTTCCA-3 and reverse, 5-
GGCCCACTCTCAATAACTCTC-3; GAPDH (NM_00
1034034, 160 bp), forward, 5-CTCTCAAGGGCATTC
TAGGC-3and reverse, 5-TGACAAAGTGGTCGTT
GAGG-3. The amplification program consisted of 15
min activation at 95°C followed by 40 cycles of PCR
steps (15 sec denaturation at 94°C, 30 sec annealing at
58°C and a 20 sec extension at 72°C). The quantification
of mRNA expression was done using Light Cycler Soft-
ware (Version 3.5; Roche). The values were normalized
using GAPDH as the internal standard. Following elec-
trophoresis of the PCR, the target band was cut out,
PCR amplicons were sequenced in both 5’ and 3’ orien-
tation to confirm the PCR amplicons as IL-8 and
GAPDH using an Applied Biosystems 3730 × l DNA
Analyzer (Applied Biosystems, Foster City CA, USA).
Statistical analysis
All data are presented as means ± SEM. The statistical
significance of differences about PMNs number, IL-8
expression of both mRNA and protein, PMN migration
levels, LEC proliferation and LEC matrigel assay was
assessed by one-way ANOVA followed by Bonferroni’s
multiple comparison test. Probabilities less than 5% (P <
0.05) were considered significant.
Results
Quantification of PMNs and IL-8 mRNA expression and
protein in the CL during the estrous cycle
The number of PMNs, IL-8 mRNA and protein during
t h ee s t r o u sc y c l ea r es h o w ni nF i g u r e1 A - C .P M N s
within the CL were detected (red-stained cells indicating
arrows) using paraffin sections stained with periodic
acid - Schiff’s (PAS) reagent (Figure 2A-F). On day 1-2
of the estrous cycle, high numbers of PMNs were
detected within the luteal tissue (Figure 1A and 2A).
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Figure 1 Number of PMNs, IL-8 mRNA expression, IL-8 secretion in the bovine CL throughout the luteal phase.F i g u r e1 A ,Ba n dC
indicate the number of PMNs, IL-8 mRNA expression in the CL and IL-8 concentration within the supernatant of the CL tissue during the estrous
cycle, respectively. Values are shown as the mean ± SEM. Different superscript letters indicate significant differences (P < 0.05) as determined by
ANOVA followed by the Bonferroni’s multiple comparison test.
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higher numbers on Day 3-4 and 5-7 in the early stage of
the estrous cycle (Figure 1A, 2B and 2C, P < 0.01), and
then reduced mid- (Figure 1A and 2D), late- (Figure 1A
and 2E) and luteal regression (Figure 1A and 2F).
IL-8 mRNA expression was higher in the early (espe-
cially Days 1-4) and regression luteal phases (days 18 or
greater) compared with mid and/or late luteal phases of
the estrous cycle (Figure 1B). IL-8 concentration within
t h es u p e r n a t a n to ft h eC Lt i s s u ei ss h o w ni nF i g u r e1 C .
Early CL had highest levels of IL-8 during the estrous
cycle, and IL-8 in regressing CL was higher than in mid
and late CL (Figure 1C). Also, we investigated IL-8
mRNA expression depending on the LCs, LECs and
PMNs (Figure 3). PMNs were the highest expression of
IL-8 mRNA, and IL-8 mRNA was expressed higher
levels in LECs compared to LCs.
PMN migration by CL supernatant derived from the early
and mid CL, and PMN migration by the early-phase CL
supernatant with or without anti-IL-8 antibody pre-
treatment
Based on the results of Figure 1-2, we hypothesized that
PMN infiltration is dependent on a chemoattractant
produced by the CL, especially IL-8. Before PMNs
migration experiment, we evaluated the purity of PMNs
separation from white blood cells using flow cytometry.
Figure 4A indicates the plotting data of peripheral white
blood cells (not separate between PMNs and pheripheral
blood mononuclear cells (PBMCs)). After removing
PBMCs layer using Lymphoprep, we observed clear
separation of PMN population (Figure 4B) and the pur-
ity of PMNs was > 95% and these cells resulted in nearly
pure granulocyte populations as determined by flow
cytometric evaluation. PMN migration by the superna-
tant obtained from early- and mid-phase CL cultures
are shown in Figure 4C. The data show that the super-
natant obtained from the early CL significantly induced
PMN migration as well as IL-8 (50 ng/ml as a positive
control) compared with control (culture medium was
applied in the bottom chamber). The supernatant from
the mid-phase CL could not induce PMN migration. To
investigate the possible role of IL-8 as a neutrophil-spe-
cific chemoattractant in early-phase CL tissue culture
supernatant, we inhibited IL-8 function using anti-IL-8
monoclonal antibody react with the bovine IL-8 (Ab;
MAB1044, Millipore Corporation, Australia) and then
performed a transmigration assay. Based on the PMN
migration ratio in the without anti-IL-8 antibody pre-
treatment group (control IgG treatment), the level of
PMN migration was significantly lower in the IL-8 anti-
body pre-treatment group compared with the control
IgG-treatment group (n = 4, Figure 4D).
Effect of IL-8 and PMNs on the function of luteal
endothelial cells
Figure 5A-E shows the effect of IL-8 and PMNs on the
function of luteal endothelial cells (LEC) in vitro.F G F 2
(10 ng/ml) was used as a positive control as general
angiogenic factor. In Figure 5A, the data show that IL-8
at 10 and 100 ng/ml as well as FGF2 stimulated live cell
number of LECs at 48 h compared with control. To
investigate the ability of IL-8 and PMNs for angiogen-
esis, LEC capillary tube formation was evaluated using
matrigel and tubular formation was assessed by the
length of capillary-like tube structure and the area of
tubular structure as previously described [29]. The data
show that IL-8 at 10 and 100 ng/ml as well as FGF2 sti-
mulated the length of capillary-like tube structure
(A) Day 1-2 (B) Day 3-4 (C) Day 5-7
(E) Day 13-16 (D) Day 8-12
50μm
(F) Day 18-20
PMNs within the CL
Figure 2 Distribution of PMNs in the bovine CL throughout the
luteal phase. Figure 2A-F indicate typical images of PMNs by PAS
staining in the CL during the estrous cycle. Black arrows indicate
PMNs. PMNs were clear granule and segmented nuclear. As Figure
1A, on day 1-2 and 3-4 of the estrous cycle, high numbers of PMNs
were detected within the luteal tissue (Figure 2A and B). Scale bars
indicate 50 μm.
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Page 5 of 10(Figure 5B) and the area of tubular structure (Figure 5C)
at 8 h compared with control (n = 4, P < 0.05). Typical
images of tubular formation of LEC of control, IL-8 (10
a n d1 0 0n g / m l )a n dF G F 2a r es h o w ni nF i g u r e6 A - D ,
respectively.
To investigate of PMNs for the function of LEC, PMNs
from the early luteal phase were cultured to activate in the
presence of N-formyl-methionyl-leucyl-phenylalanine
(fMLP; 10 and 100 nM) or without fMLP as control for 1
h at 37°C as previously described [15]. After stimulation of
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Figure 4 PMN migration by the supernatant of early and mid CL culture and PMN migration levels with or without anti-IL-8 Ab pre-
treatment. Before PMNs migration experiment, we evaluated the purity of PMNs separation from white blood cells using flow cytometry. Figure
4A indicates the plotting data of peripheral white blood cells (not separate between PMNs and pheripheral blood mononuclear cells (PBMCs)).
After removing PBMCs layer using Lymphoprep, we observed clear separation of PMN population (Figure 4B) and the purity of PMNs was > 95%
and these cells resulted in nearly pure granulocyte populations as determined by flow cytometric evaluation. PMN migration by the supernatant
obtained from early- and mid-phase CL cultures are shown in Figure 4C. The supernatant of the early CL significantly induced PMN migration as
well as IL-8 (50 ng/ml as a positive control) compared with control. Figure 4D indicates the reduction ratio of migrated PMNs using the
supernatant of the early CL with anti-IL-8 monoclonal antibody or control IgG. All values are the mean ± SEM. Different superscript letters
indicate significant differences (P < 0.05) as determined by ANOVA followed by the Bonferroni’s multiple comparison test.
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Page 6 of 10PMNs by fMLP, supernatant of activated PMNs was har-
vested and then used for the assessment of capillary tube
formation (Figure 5D and 5E). An in vitro matrigel assay,
the supernatant of activated-PMNs stimulated sprouting
of capillary-like structures of LECs (n = 4, P < 0.05) com-
pared with control (culture medium alone) and normal
PMNs (un-activated supernatant of PMNs). Typical
images of tubular formation of LEC of control, fMLP-sti-
mulated PMNs (10 and 100 nM) and normal PMNs are
shown in Figure 6E-H, respectively.
Discussion
This study demonstrated the presence of PMN popula-
tions and IL-8 expression (mRNA and protein) within
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Figure 5 Effects of IL-8 and activated PMNs on live cell number and tubular formation of LEC. Figure 5A-C shows the effect of IL-8 and
PMNs on the function of LECs in vitro. Figure 5A shows that IL-8 at 10 and 100 ng/ml as well as FGF2 stimulated live cell number of LECs. The
data show that IL-8 at 10 and 100 ng/ml as well as FGF2 stimulated the length of capillary-like tube (Figure 5B), and the area of tubular structure
(Figure 5C, n = 4). Figure 5D and E shows the effects of PMNs on tubular formation of LECs. PMNs from the early luteal phase were cultured to
activate in the presence of fMLP (10 and 100 nM) or without fMLP. An in vitro matrigel assay, the supernatant of activated-PMNs stimulated
sprouting of capillary-like structures of LECs (n = 4, P < 0.05) compared with control and normal PMNs (non-activated supernatant of PMNs).
Values are shown as the mean ± SEM. Different superscript letters indicate significant differences (P < 0.05) as determined by ANOVA followed
by the Bonferroni’s multiple comparison test.
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Figure 6 Image of tubular formation of LEC by IL-8 and activated PMNs. Typical images of tubular formation of LEC of control, IL-8 (10 and
100 ng/ml), FGF2 (positive control), fMLP-stimulated PMNs (10 and 100 nM) and normal PMNs are shown in Figure 6A-H, respectively. Scale bars
indicate 200 μm
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Page 7 of 10the CL during the estrous cycle in cows. Particularly,
PMNs and IL-8 expression were predominant in the
very early stage of the luteal phase. The early bovine CL
induced PMN migration at least in part via IL-8 in
vitro, and PMNs as well as IL-8 stimulated capillary-like
structures of LECs in vitro. These findings suggest that
PMNs and IL-8, a neutrophil-specific chemoattractant,
have important roles in CL angiogenesis in cows.
The CL formation occurs by the rapidly induced term-
inal differentiation of granulosa and theca cells into
luteal cells and promotes tissue transformation including
break-down of the follicular basal lamina and migration
of various cell types, such as leukocytes and endothelial
cells into the granulosa layer, which eventually leads to
neovascularization. In the present study, the early bovine
CL, specifically days 1-4 of the estrous cycle possessed a
large number of PMNs together with high levels of IL-8
expression (Figure 1). Therefore, we hypothesized that
PMNs infiltrated via IL-8 in the developing CL may
play a role in angiogenesis of the CL.
To investigate the role of PMNs and IL-8 in CL devel-
opment, we focused on the mechanism of PMN migra-
tion in the bovine CL. In the present study, we
investigated the factors secreted from the CL to induce
migration of PMNs. The early CL produced a greater
quantity of IL-8, a good candidate of neutrophil-specific
chemoattractant compared to the mid CL. Indeed, PMN
migration was stimulated by the supernatant from the
early CL but not from the mid CL, and this active PMN
migration in the early CL was partially inhibited by pre-
treatment with anti-IL-8 antibody (Figure 4D). However,
treatment of IL-8 antibody could not completely inhib-
ited (only 40%) the PMN migration by the supernatant
of the early CL. Interestingly, as in the case of IL-8,
FGF2 and VEGFA (10 and 100 ng/ml) stimulated PMN
migration in vitro (our preliminary study, data not
shown), and FGF2 and VEGFA are also expressed at
high levels within the developing CL. Indeed, Ancelin et
al. demonstrated that VEGFA was chemotactic for neu-
trophils in humans and that a neutralizing with anti-
VEGF antibody blocked this effect [14]. FGF2 also
enhanced recruitment of neutrophils in rats [33]. There-
fore, we speculate that IL-8, VEGFA, and FGF2 are act-
ing synergistically as stimulators of PMN recruitment in
the early CL in cows. We have to continuously investi-
gate about this hypothesis in future study.
To elucidate our hypothesis that PMNs and IL-8 may
p l a yar o l ei na n g i o g e n e s i so ft h eC L ,w ei n v e s t i g a t e d
the effects of PMNs and IL-8 on the function of LECs
in vitro. Similar to FGF2 as a strong angiogenic factor,
IL-8 increased proliferation of LECs and stimulated
sprouting of capillary-like structures of LECs in in vitro
matrigel assay. On the other hand, it has been reported
that human PMNs stimulated by 100 nM fMLP secretes
substantial amount of IL-8 at 1 h after stimulation and
is able to induce sprouting of capillary-like structures
[15,29]. As referred these previous study, the superna-
tant of activated-PMNs by fMLP as well as FGF2 in the
present study, stimulated sprouting of capillary-like
structures of LECs in in vitro matrigel assay, suggesting
the crucial role of PMNs-IL-8 axis in the developing CL
in cows. Actually, PMNs and IL-8 can induce angiogen-
esis in vivo [16,21] and in vitro [15,29], suggesting that
the PMNs-IL-8 duo may function not only in the induc-
tion of tissue inflammation and wound healing, but also
in the regulation of angiogenesis.
Angiogenesis is a critical component of normal luteal
function, and FGF2 and VEGFA are major angiogenic
factors in the bovine CL [34-37]. Indeed, Robinson et
al., demonstrated that in a luteal angiogenesis culture
system (involves luteal cells, endothelial cells and
smooth muscle cells), a physiological dose (1 ng/ml) of
FGF2 and VEGFA stimulates the degree of the endothe-
lial cell network [35]. In addition, we recently showed
that treatment with FGF2 and VEGFA antibodies mark-
edly suppressed angiogenesis in the early luteal phase of
the bovine CL in vivo [37]. VEGFA stimulated the
mRNA expression of IL-8 in bovine theca [38] and
human endothelial cells [15]. These findings suggest
that PMNs and IL-8 together with FGF2 and VEGFA
actively contribute to induce angiogenesis during the
early CL development.
Similarly to PMNs in the present study, macrophages
and lymphocytes have been identified in the developing
CL in several species [11,39-41], and have been sug-
gested to be putative intraovarian regulators. Indeed,
peripheral blood lymphocytes and macrophages indi-
cated a luteotrophic effect as these cells stimulated P
secretion upon co-culture with granulosa cells [42-44].
Meanwhile, Furukawa et al. revealed that platelets are
novel regulators of neovascularization and luteinization
during the early luteal phase in humans [45]. An
increased number of platelets localized to extravascular
sites among luteinizing granulosa cells after ovulation
and gradually decreased toward the mid luteal phase
[45], that are similar to the PMN profile observed in the
present study. Moreover, platelets stimulated P secretion
in luteinizing granulosa cells and endothelial cell migra-
tion [45]. Taken together, these findings suggest that
immune and blood cells are active components in CL
development including angiogenesis, luteinization and P
secretion.
Conclusion
This study showed that PMNs migrate into the early CL
partially due to its major chemoattractant IL-8 pro-
duced at high levels in the CL, and they are most likely
to be involved in the regulation of angiogenesis. Thus,
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Page 8 of 10PMNs are novel regulators of early CL development in
the cow.
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